Purchase Order 75F40124P00142
Award Date 5/15/24
Potential Completion Date 12/14/25
Potential Value $220K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract awarded to Drexel University by the Food and Drug Administration (FDA) is for immunopathology analysis of patient tissue samples from cardiovascular and/or orthopedic device implants. The $299,778.10 firm-fixed price contract has a period of performance running from September 2022 through March 2024. There is no set-aside designation used for this award. The original solicitation sought offerors with experience in similar tissue sample analysis to complete tasks such as...
- The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
- The U.S. Food and Drug Administration (FDA) awarded a $901,888.19 definitive contract to the National Academy of Sciences (NAS), a non-profit organization, to produce a consensus report that identifies innovative technologies to advance pharmaceutical manufacturing. The contract, which is not set aside, was awarded on July 19, 2019 with a completion date of March 31, 2022. The report will assist the FDA's Center for Drug Evaluation and Research (CDER) in fostering the adoption of innovative...
- The Department of Health and Human Services Food and Drug Administration awarded a $169,918.01 firm fixed price delivery order contract to We Pharma, Inc. of Morrisville, North Carolina. The purpose of this requirement is to obtain currently marketed drug products for FDA research studies. We Pharma will provide the requested products to the FDA under this contract, which has a completion date of September 29, 2021. No set-aside designation was used for this award made on September 30, 2020.
- The U.S. Food and Drug Administration (FDA) awarded a $1,000,000.00 definitive contract to the Regents of the University of Michigan to conduct research on the "Influence of Raw Materials Manufacturing Variables and Storage Conditions on Release Performance of Long Acting Release Microsphere Products." This is a cost-no-fee contract with a completion date of September 29, 2019. The University of Michigan is a U.S. Government Entity providing educational services and has extensive...
- The Department of Health and Human Services Food and Drug Administration awarded a $139,656 firm fixed price delivery order contract to Dun & Bradstreet Inc., doing business as D&B, to provide Bradstreet task order/data services to assist regulatory analyses. The single award was made against an unspecified government-wide acquisition contract vehicle. D&B will utilize its data and analytics services to support the FDA's work in Silver Spring, Maryland through September 2021. No...
- This delivery order, awarded November 3, 2025, represents a $489,055.52 firm fixed price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery to support federal healthcare needs. The contract is a child order under an Indefinite Delivery Contract vehicle and involves no set-aside designation, indicating competitive award through open competition. The awardee, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location with a...
- The Food and Drug Administration awarded a $2.24 million firm fixed-price definitive contract to the Regents of the University of Michigan on September 12, 2024, to conduct research on stimulant and opioid use disorder trajectories and associated consequences in U.S. adults using a mosaic approach. The contract, which will be performed at the University of Michigan in Ann Arbor, Michigan, is scheduled for completion by September 29, 2028. This research aligns with FDA's public health mission and...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $66,145 firm fixed price delivery order to Data Federal Corporation under the agency's Multiple Award Schedule contract vehicle. The order is associated with the FDA's Shelf Life Extension Program and provides for electronic records storage and document management services to support the agency's efforts to extend expiration dates of stockpiled strategic national stockpile pharmaceuticals and medical...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Ddbst - Dortmund Data Bank Software & Separation Technology GMBH, a for-profit organization, for UNIFAC CONSORTIUM MEMBERSHIP. The contract has a ceiling value of $35,637.91 and a period of performance through September 16, 2025. The contract was awarded on September 8, 2020 and does not have a set-aside designation. The original solicitation was posted on...